Search research articles
Contact Us
Filters
Showing results (281-290 of 322) with videos related to
Page
of 33
Sort By:
The Journal of Experimental Medicine
|
April 1, 1994
Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130
X G Zhang, J J Gu, Z Y Lu, et al.
British Journal of Haematology
|
December 1, 1996
A pilot study of 220 mg/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity
P Moreau, M F Kergueris, N Milpied, et al.
ACS Chemical Biology
|
August 30, 2019
A Biased Agonist at Immunometabolic Receptor GPR84 Causes Distinct Functional Effects in Macrophages
Daniel Lucy, Gareth S D Purvis, Lynda Zeboudj, et al.
Nature Structural & Molecular Biology
|
February 9, 2010
Systematic identification of fragile sites via genome-wide location analysis of gamma-H2AX
Rachel K Szilard, Pierre-Etienne Jacques, Louise Laramée, et al.
British Journal of Cancer
|
December 4, 2023
Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia
Angela Gutierrez-Camino, Chantal Richer, Manon Ouimet, et al.
Genome Research
|
April 12, 2006
Genome-wide computational prediction of transcriptional regulatory modules reveals new insights into human gene expression
Mathieu Blanchette, Alain R Bataille, Xiaoyu Chen, et al.
Blood
|
November 15, 1996
Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop
Z J Gu, V Costes, Z Y Lu, et al.
Blood
|
May 1, 1995
Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells
Z Y Lu, X G Zhang, C Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 1998
CD28, a marker associated with tumoral expansion in multiple myeloma
N Robillard, G Jego, C Pellat-Deceunynck, et al.
Human Mutation
|
August 29, 2001
High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis
S Bezieau, M C Devilder, H Avet-Loiseau, et al.
Page
of 33
Search research articles
Search
Showing results (281-290 of 322) with videos related to
Sort By:
Page
of 33
The Journal of Experimental Medicine
|
April 1, 1994
Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130
X G Zhang, J J Gu, Z Y Lu, et al.
British Journal of Haematology
|
December 1, 1996
A pilot study of 220 mg/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity
P Moreau, M F Kergueris, N Milpied, et al.
ACS Chemical Biology
|
August 30, 2019
A Biased Agonist at Immunometabolic Receptor GPR84 Causes Distinct Functional Effects in Macrophages
Daniel Lucy, Gareth S D Purvis, Lynda Zeboudj, et al.
Nature Structural & Molecular Biology
|
February 9, 2010
Systematic identification of fragile sites via genome-wide location analysis of gamma-H2AX
Rachel K Szilard, Pierre-Etienne Jacques, Louise Laramée, et al.
British Journal of Cancer
|
December 4, 2023
Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia
Angela Gutierrez-Camino, Chantal Richer, Manon Ouimet, et al.
Genome Research
|
April 12, 2006
Genome-wide computational prediction of transcriptional regulatory modules reveals new insights into human gene expression
Mathieu Blanchette, Alain R Bataille, Xiaoyu Chen, et al.
Blood
|
November 15, 1996
Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop
Z J Gu, V Costes, Z Y Lu, et al.
Blood
|
May 1, 1995
Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells
Z Y Lu, X G Zhang, C Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 1998
CD28, a marker associated with tumoral expansion in multiple myeloma
N Robillard, G Jego, C Pellat-Deceunynck, et al.
Human Mutation
|
August 29, 2001
High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis
S Bezieau, M C Devilder, H Avet-Loiseau, et al.
Page
of 33